Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 23691304)

1.

New oral anticoagulants in the treatment of pulmonary embolism: efficacy, bleeding risk, and monitoring.

Rudd KM, Phillips EL.

Thrombosis. 2013;2013:973710. doi: 10.1155/2013/973710. Epub 2013 Apr 10.

2.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
3.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
4.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
5.

New anticoagulants: focus on venous thromboembolism.

Gómez-Outes A, Lecumberri R, Pozo C, Rocha E.

Curr Vasc Pharmacol. 2009 Jul;7(3):309-29. Review.

PMID:
19601856
6.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
7.

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W.

Circulation. 2012 Nov 13;126(20):2381-91. doi: 10.1161/CIRCULATIONAHA.112.115410. Epub 2012 Oct 15. Review.

8.

Respiratory review of 2014: pulmonary thromboembolism.

Lee JS.

Tuberc Respir Dis (Seoul). 2014 Sep;77(3):105-10. doi: 10.4046/trd.2014.77.3.105. Epub 2014 Sep 30. Review.

10.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
11.

Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.

Baker WL, Phung OJ.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):711-9. Epub 2012 Aug 21. Review.

12.

[New oral anticoagulants for treatment of venous thromboembolism].

Espinola-Klein C, Weisser G.

Dtsch Med Wochenschr. 2011 Jun;136(22):1162-4. doi: 10.1055/s-0031-1280530. Epub 2011 May 24. German.

PMID:
21611919
13.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
14.

The role of prothrombin complex concentrates in reversal of target specific anticoagulants.

Babilonia K, Trujillo T.

Thromb J. 2014 Apr 17;12:8. doi: 10.1186/1477-9560-12-8. eCollection 2014. Review.

15.

The new oral anticoagulants for the treatment of venous thromboembolism: a new paradigm shift in antithrombotic therapy.

Galanis T, Keiffer G, Merli G.

Curr Ther Res Clin Exp. 2014 Sep 28;76:76-83. doi: 10.1016/j.curtheres.2014.06.002. eCollection 2014 Dec. Review.

16.

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.

Int Angiol. 2012 Aug;31(4):330-9. Review.

PMID:
22801398
17.

Acute pulmonary embolism: risk assessment, risk stratification and treatment options.

Piovella F, Iosub DI.

Clin Respir J. 2015 Jan 26. doi: 10.1111/crj.12264. [Epub ahead of print]

PMID:
25619266
18.

[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].

Dumont B, Faille D, Ajzenberg N.

Med Sci (Paris). 2011 May;27(5):493-500. doi: 10.1051/medsci/2011275014. Epub 2011 May 25. Review. French.

19.

Emerging anticoagulants for venous thromboembolism prevention.

Trujillo TC.

Am J Health Syst Pharm. 2010 May 15;67(10 Suppl 6):S17-25. doi: 10.2146/ajhp100178. Review.

PMID:
20479087
20.

Long-term benefits of preventing venous thromboembolic events.

Cohen AT.

Curr Med Res Opin. 2012 Jun;28(6):877-89. doi: 10.1185/03007995.2012.688737. Epub 2012 May 24. Review. Erratum in: Curr Med Res Opin. 2012 Sep;28(9):1574. Dosage error in article text.

PMID:
22533680
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk